Recent study results show that the single-target DNA methylation test performed with a negative predictive value of 97.6 percent.

Further confirmation in a large-scale, prospective manner would bolster clinical utility, and efforts to expand predictive capabilities to FGFR3 fusions or other novel targets would align with the ...

This blog explores the benefits of applying Large Language Models to extract information from pathology reports, which allows us to quickly curate bespoke structured data from unstructured reports ...

2018.0801. PMID: 30642428; PMCID: PMC6365675. Wang P, Zang S, Li G, Qu W, Li S, Qiao Q, Jiang Y. The role of surgery on the primary tumor site in bladder cancer with distant metastasis: significance ...

A bladder spasm, also known as detrusor hyperreflexia, occurs when the bladder muscle squeezes involuntarily without warning. In addition to pain or discomfort, the spasms can lead to bladder leakage ...

A list of facts and trends to know about the current landscape of urologic cancer management and research in the US.

Using multiparametric MRI (mpMRI) before surgery reduced time to correct treatment by 45 days for patients with muscle invasive bladder cancer. The imaging procedure was successful for over 92% of ...

Overactive bladder (OAB) is typically not painful, but it can cause significant discomfort and a sudden, strong urge to urinate. OAB causes sudden, involuntary contractions of the bladder muscle ...

Too much water or other fluid Overfills the bladder. Drink no more than 2 liters (about 2 quarts) of fluid a day. Drink most fluids during the daytime and limit fluids in the evening. Causes ...

Millions of Americans have neurogenic bladder. Neurogenic bladder is when a person lacks bladder control due to a brain, spinal cord or nerve problem. This includes people with Multiple Sclerosis (MS) ...

Incontinence is defined as the involuntary leakage of urine from the bladder. Incontinence can affect both men and women in any age group but is more common in women and the elderly. As the population ...

Veracyte Announces 17 Abstracts Demonstrating Its Decipher Tests’ Leadership in Urologic Cancers Will Be Presented at the 2025 ASCO GU Symposium.